ASH
Ashland Inc. NYSE Listed Mar 17, 1980$67.92
+5.53%
vs $64.36
Mkt Cap $3.1B
52w Low $47.49
100.0% of range
52w High $67.92
50d MA $57.46
200d MA $55.84
P/E (TTM)
-3.7x
EV/EBITDA
—
P/B
1.6x
Debt/Equity
0.8x
ROE
27.1%
P/FCF
-781.1x
RSI (14)
79.40
ATR (14)
$2.28
Beta
0.44
50d MA
$57.46
200d MA
$55.84
Avg Volume
1.1M
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
8145 Blazer Drive · Wilmington, DE 19808 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | AMC | 0.97 | 0.91 | -6.2% | 57.00 | -3.9% | -13.8% | +8.4% | -2.7% | +1.4% | -0.5% | — |
| Feb 2, 2026 | AMC | 0.23 | 0.26 | +13.0% | 61.56 | -3.2% | -0.8% | +5.7% | -2.2% | +1.6% | -3.0% | — |
| Nov 4, 2025 | AMC | 1.17 | 1.08 | -7.7% | 47.84 | +0.4% | +6.1% | -0.9% | -0.5% | -0.3% | +0.3% | — |
| Jul 29, 2025 | AMC | 1.15 | 1.04 | -9.6% | 50.18 | +0.6% | +5.6% | -2.7% | -2.1% | +0.5% | +2.6% | — |
| Apr 30, 2025 | AMC | 1.10 | 0.99 | -10.0% | 54.39 | -9.5% | -9.9% | +0.8% | +0.5% | -3.1% | +0.5% | — |
| Jan 28, 2025 | AMC | 0.79 | 0.28 | -64.6% | 71.16 | -1.8% | -9.8% | -0.7% | -0.4% | -4.1% | +5.8% | — |
| Nov 7, 2024 | AMC | 1.28 | 1.26 | -1.6% | 80.70 | +0.2% | +0.3% | -2.7% | -2.0% | +0.3% | +0.8% | — |
| Aug 6, 2024 | AMC | 1.47 | 1.49 | +1.4% | 90.39 | -8.4% | -9.6% | +1.7% | -1.3% | +1.5% | +0.1% | — |
| Apr 30, 2024 | AMC | 1.14 | 1.27 | +11.4% | 95.33 | +2.0% | -0.9% | +1.4% | +0.1% | +1.6% | +0.7% | — |
| Jan 30, 2024 | AMC | 0.19 | 0.45 | +136.8% | 80.77 | +11.1% | +15.9% | +0.9% | -3.1% | -0.7% | -0.6% | — |
| Nov 8, 2023 | AMC | 0.47 | 0.41 | -12.8% | 76.55 | -1.4% | -4.8% | -0.5% | +1.0% | +4.1% | +0.9% | — |
| Jul 25, 2023 | AMC | 1.27 | 1.23 | -3.1% | 91.81 | +0.8% | -1.1% | +0.7% | +0.5% | -0.5% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6 | Seaport Research Partners | Upgrade | Neutral → Buy | $75 | $52.26 | $54.45 | +4.2% | +4.5% | -0.2% | +1.0% | -1.7% | +4.9% |
| Apr 30 | JP Morgan | Maintains | Overweight → Overweight | — | $49.15 | $49.07 | -0.2% | +8.4% | -2.7% | +1.4% | -0.5% | +4.5% |
| Apr 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $49.15 | $49.07 | -0.2% | +8.4% | -2.7% | +1.4% | -0.5% | +4.5% |
| Mar 23 | Argus | Maintains | Buy → Buy | — | $48.81 | $50.17 | +2.8% | +2.3% | +1.8% | +5.5% | +1.1% | -1.9% |
| Feb 18 | Evercore ISI | Maintains | In Line → In Line | — | $60.23 | $60.37 | +0.2% | +5.2% | -0.3% | +2.5% | -2.7% | +1.7% |
| Feb 4 | JP Morgan | Maintains | Overweight → Overweight | — | $61.08 | $61.95 | +1.4% | +5.7% | -2.2% | +1.6% | -3.0% | +0.4% |
| Jan 12 | Argus | Maintains | Buy → Buy | — | $62.34 | $62.31 | -0.0% | +3.2% | -0.4% | +0.7% | -0.6% | -2.0% |
| Jan 12 | UBS | Maintains | Buy → Buy | — | $62.34 | $62.31 | -0.0% | +3.2% | -0.4% | +0.7% | -0.6% | -2.0% |
| Dec 19 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $59.27 | $59.10 | -0.3% | +0.3% | +0.0% | -0.7% | +0.5% | +0.5% |
| Dec 18 | Mizuho | Maintains | Outperform → Outperform | — | $59.77 | $59.77 | +0.0% | -0.8% | +0.3% | +0.0% | -0.7% | +0.5% |
| Dec 15 | BMO Capital | Upgrade | Market Perform → Outperform | — | $59.15 | $61.06 | +3.2% | +1.1% | -2.0% | +1.9% | -0.8% | +0.3% |
| Nov 17 | Mizuho | Maintains | Outperform → Outperform | — | $51.51 | $51.60 | +0.2% | -3.7% | +0.8% | -2.0% | -1.7% | +4.5% |
| Nov 11 | Evercore ISI | Maintains | In Line → In Line | — | $49.89 | $50.15 | +0.5% | +0.3% | +0.0% | +6.1% | -3.0% | -3.7% |
| Nov 11 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $49.89 | $50.15 | +0.5% | +0.3% | +0.0% | +6.1% | -3.0% | -3.7% |
| Oct 15 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $49.01 | $49.26 | +0.5% | +0.0% | -0.2% | -0.2% | +2.2% | +1.4% |
| Oct 3 | Mizuho | Maintains | Outperform → Outperform | — | $48.54 | $48.53 | -0.0% | +0.2% | +0.7% | -3.1% | +2.3% | -0.2% |
| Sep 2 | BMO Capital | Maintains | Market Perform → Market Perform | — | $56.15 | $55.67 | -0.9% | -2.3% | -1.3% | +0.1% | +1.2% | -0.6% |
| Aug 26 | Argus | Maintains | Buy → Buy | — | $56.25 | $56.13 | -0.2% | -0.3% | +0.8% | +0.1% | -0.8% | -2.3% |
| Aug 7 | UBS | Maintains | Buy → Buy | — | $51.63 | $52.54 | +1.8% | +2.2% | -1.3% | -0.9% | +2.9% | +3.4% |
| Jul 31 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $52.98 | $52.35 | -1.2% | -2.7% | -2.1% | +0.5% | +2.6% | -0.9% |
| Jul 9 | UBS | Maintains | Buy → Buy | — | $53.97 | $54.13 | +0.3% | +0.0% | +0.9% | -1.9% | -1.8% | -2.6% |
| May 6 | JP Morgan | Maintains | Overweight → Overweight | — | $49.69 | $48.62 | -2.2% | -3.1% | +0.5% | +3.3% | +0.2% | +5.4% |
| May 1 | UBS | Maintains | Buy → Buy | — | $54.39 | $49.25 | -9.5% | -9.9% | +0.8% | +0.5% | -3.1% | +0.5% |
| May 1 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $54.39 | $49.25 | -9.5% | -9.9% | +0.8% | +0.5% | -3.1% | +0.5% |
| Apr 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $46.53 | $45.57 | -2.1% | +11.2% | -6.1% | +4.0% | +0.3% | -0.6% |
| Mar 27 | Wells Fargo | Maintains | Overweight → Overweight | — | $59.72 | $59.25 | -0.8% | +0.1% | -1.2% | +0.5% | -2.5% | +0.2% |
| Mar 26 | JP Morgan | Upgrade | Neutral → Overweight | — | $56.93 | $59.01 | +3.7% | +4.9% | +0.1% | -1.2% | +0.5% | -2.5% |
| Mar 5 | Seaport Global | Downgrade | Buy → Neutral | — | $56.60 | $56.74 | +0.2% | +5.0% | +0.4% | -2.1% | -1.7% | -0.2% |
| Jan 30 | JP Morgan | Maintains | Neutral → Neutral | — | $64.17 | $64.19 | +0.0% | -0.7% | -0.4% | -4.1% | +5.8% | -0.2% |
| Jan 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $64.17 | $64.19 | +0.0% | -0.7% | -0.4% | -4.1% | +5.8% | -0.2% |
| Jan 29 | UBS | Maintains | Buy → Buy | — | $71.16 | $69.90 | -1.8% | -9.8% | -0.7% | -0.4% | -4.1% | +5.8% |
| Dec 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $75.87 | $75.98 | +0.1% | -1.2% | -1.1% | +0.9% | -1.4% | -0.9% |
| Dec 11 | BMO Capital | Maintains | Market Perform → Market Perform | — | $75.87 | $75.98 | +0.1% | -1.2% | -1.1% | +0.9% | -1.4% | -0.9% |
| Nov 19 | BMO Capital | Maintains | Market Perform → Market Perform | — | $77.03 | $75.54 | -1.9% | -0.8% | -0.2% | +1.9% | +1.8% | +0.9% |
| Aug 15 | UBS | Maintains | Buy → Buy | — | $82.85 | $84.28 | +1.7% | +2.8% | -0.2% | +2.0% | -0.8% | +1.3% |
| Aug 9 | BMO Capital | Maintains | Market Perform → Market Perform | — | $83.11 | $83.80 | +0.8% | -1.3% | +1.4% | +0.1% | -0.6% | +2.8% |
| Aug 8 | JP Morgan | Upgrade | Underweight → Neutral | — | $81.74 | $83.08 | +1.6% | +1.7% | -1.3% | +1.4% | +0.1% | -0.6% |
| Aug 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $81.74 | $83.08 | +1.6% | +1.7% | -1.3% | +1.4% | +0.1% | -0.6% |
| May 7 | BMO Capital | Maintains | Market Perform → Market Perform | — | $97.34 | $97.58 | +0.2% | +0.7% | -0.5% | +0.3% | +0.2% | -0.1% |
| May 2 | JP Morgan | Maintains | Underweight → Underweight | — | $94.50 | $96.64 | +2.3% | +1.4% | +0.1% | +1.6% | +0.7% | -0.5% |
| May 1 | UBS | Maintains | Buy → Buy | — | $95.33 | $97.22 | +2.0% | -0.9% | +1.4% | +0.1% | +1.6% | +0.7% |
| May 1 | Mizuho | Maintains | Buy → Buy | — | $95.33 | $97.22 | +2.0% | -0.9% | +1.4% | +0.1% | +1.6% | +0.7% |
| Apr 11 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $94.41 | $96.29 | +2.0% | +1.9% | -1.0% | -1.7% | +0.4% | -0.1% |
| Mar 14 | Jefferies | Upgrade | Hold → Buy | — | $95.50 | $96.90 | +1.5% | +0.7% | +0.7% | -1.4% | +0.5% | +1.5% |
| Feb 1 | JP Morgan | Maintains | Underweight → Underweight | — | $93.62 | $96.73 | +3.3% | +0.9% | -3.1% | -0.7% | -0.6% | +0.3% |
| Feb 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $93.62 | $96.73 | +3.3% | +0.9% | -3.1% | -0.7% | -0.6% | +0.3% |
| Nov 15 | BMO Capital | Maintains | Market Perform → Market Perform | — | $76.15 | $75.51 | -0.8% | +0.9% | -0.5% | +0.6% | +1.8% | -0.5% |
| Nov 13 | Stifel | Maintains | Buy → Buy | — | $72.45 | $72.36 | -0.1% | +1.0% | +4.1% | +0.9% | -0.5% | +0.6% |
| Nov 9 | UBS | Maintains | Buy → Buy | — | $76.55 | $75.51 | -1.4% | -4.8% | -0.5% | +1.0% | +4.1% | +0.9% |
| Oct 30 | Stifel | Maintains | Buy → Buy | — | $75.31 | $76.04 | +1.0% | +0.1% | +1.7% | -1.1% | +0.5% | +1.9% |
No insider trades available.
8-K · 1.01
! Medium
Ashland Inc. -- 8-K 1.01: Financing / Debt Agreement
May 29
8-K · 7.01
! Medium
Ashland Inc. -- 8-K 7.01: Regulation FD Disclosure
Ashland Inc. will release fourth-quarter and full-year 2025 financial results on February 2, 2026, available through its investor relations website.
Feb 2
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Standard Investments Llc | 2,625,000 | $146M | — | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 2,194,945 | $122M | New | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 2,052,542 | $114M | New | Mar 2026 |
| 4 | Aqr Capital Management Llc | 2,011,524 | $110M | Reduced | Mar 2026 |
| 5 | Diamond Hill Capital Management Inc | 1,801,062 | $106M | Added | Dec 2025 |
| 6 | Franklin Resources Inc | 1,742,349 | $97M | — | Mar 2026 |
| 7 | Cooperman Leon G | 1,700,000 | $95M | — | Mar 2026 |
| 8 | Frontier Capital Management Co Llc | 1,425,289 | $84M | Added | Dec 2025 |
| 9 | 1832 Asset Management L.p. | 1,415,420 | $79M | — | Mar 2026 |
| 10 | Citadel Advisors Llc | 630,236 | $35M | Added | Mar 2026 |
| 11 | Morgan Stanley | 482,920 | $28M | Reduced | Dec 2025 |
| 12 | Northern Trust Corp | 485,274 | $27M | Added | Mar 2026 |
| 13 | Newport Trust Company, Llc | 449,452 | $25M | Reduced | Mar 2026 |
| 14 | Bank Of America Corp /de/ | 445,596 | $25M | Reduced | Mar 2026 |
| 15 | Allspring Global Investments Holdings, Llc | 424,379 | $24M | Reduced | Mar 2026 |
| 16 | Boston Partners | 405,694 | $23M | Added | Mar 2026 |
| 17 | Raymond James Financial Inc | 391,463 | $21M | Reduced | Mar 2026 |
| 18 | Woodline Partners Lp | 343,889 | $19M | Added | Mar 2026 |
| 19 | Bank Of New York Mellon Corp | 308,628 | $17M | Added | Mar 2026 |
| 20 | Natixis | 300,593 | $17M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$3.12B
Enterprise Value
$4.38B
P/E (TTM)
-3.70x
Forward P/E
17.71x
PEG Ratio
0.00x
P/B
1.64x
P/S
1.71x
P/FCF
-781.08x
EV/EBITDA
—
Shares Out
46.0M
Financials (TTM)
Revenue
$1.82B
Net Income
-$845.0M
EBITDA
-$509.0M
Free Cash Flow
-$4.0M
Op Cash Flow
$94.0M
EPS Basic
$-18.37
EPS Diluted
$-18.37
EPS Forward
$3.84
Gross Margin
30.1%
Op Margin
-42.5%
Net Margin
-46.3%
Balance Sheet
Total Assets
$4.61B
Total Liab.
$2.71B
Total Equity
$1.90B
Cash
$215.0M
LT Debt
$1.47B
Book Value/Sh
$41.39
Debt/Equity
0.83x
Current Ratio
2.85
Quick Ratio
1.51
Returns & Growth
ROE
27.1%
ROA
11.2%
ROIC
-18.4%
Rev Growth YoY
-13.7%
EPS Growth YoY
-632.5%
Price Returns
2W
+3.1%
1M
+8.7%
3M
-7.2%
6M
+9.5%
12M
+16.9%
Technicals
52W High
$67.92
52W Low
$47.49
50d MA
$57.46
200d MA
$55.84
RSI (14)
79.40
ATR (14)
$2.28
Beta
0.44
Avg Volume
1.1M
Dividends
Div Rate
$1.65
Div Yield
3.2%
Frequency
4
Ex-Div Date
Feb 27, 2026
Analyst Price Targets
Consensus
$68.43
High
$73.00
Low
$62.00
Median
$70.00
Data updated apr 24, 2026 7:12pm
· Source: financialmodelingprep.com